News Releases

Year

08 August 2019

Cronos Group Inc. Announces Second Quarter and First-Half 2019 Results

Opened Cronos Device Labs , New Global R&D Center in Israel Appointed Dr. Todd Abraham as Chief Innovation Officer Announced Agreement to Acquire State-of-the-Art Fermentation Facility Established New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform TORONTO

02 August 2019

Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform

TORONTO , Aug. 02, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has entered into a definitive agreement to acquire four of Redwood Holding Group , LLC’s operating subsidiaries (collectively, “ Redwood ”).

11 July 2019

Cronos Group Enters Agreement to Acquire State-of-the-Art Fermentation and Manufacturing Facility

Facility Advances Partnership with Ginkgo Bioworks; Will Enable Production of Cultured Cannabinoids at Commercial Scale TORONTO , July 11, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has entered into an

09 July 2019

Cronos Group Appoints Dr. Todd Abraham as Chief Innovation Officer

36-Year CPG Executive Brings Extensive Experience in Identifying, Developing and Commercializing Breakthrough Technology for Consumer Goods Sector TORONTO , July 09, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that Dr.

08 July 2019

Cronos Group Inc. to Hold Second Quarter 2019 Earnings Conference Call

TORONTO , July 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), will announce its financial results for the second quarter ended June 30, 2019, and hold its Second Quarter 2019 Earnings Conference Call on Thursday, August 8,

19 June 2019

Cronos Group Inc. Announces Results of Vote for Election of Directors

TORONTO , June 19, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) reports that at its Annual Meeting of Shareholders on June 19, 2019 there were 610 shareholders voting in person or by proxy holding in total 261,290,314 common shares,

30 May 2019

Cronos Group Inc. to Present at Piper Jaffray 39th Annual Consumer Marketplace Conference, Jefferies 2019 Healthcare Conference and Stifel 2019 Cross Sector Insight Conference

TORONTO , May 30, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“ Cronos Group” or the “Company”) (TSX: CRON) (Nasdaq: CRON), an innovative global cannabinoid company, today announced that Mike Gorenstein , Chairman, President and Chief Executive Officer, will speak at three industry conferences in

29 May 2019

Cronos Group Inc. Sets Date for 2019 Annual Meeting of Shareholders

TORONTO , May 29, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), an innovative global cannabinoid company, will hold its 2019 Annual Meeting of Shareholders on Wednesday, June 19, 2019 at 10 a.m.

14 May 2019

Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement

Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement TORONTO , May 14, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), is pleased to announce that it has entered into a multi-year supply agreement with

09 May 2019

Cronos Group Inc. Announces First Quarter 2019 Results

Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs , a State-of-the-Art Vaporizer R&D Initiative NatuEra Receives License to Cultivate Psychoactive Cannabis in Colombia Spinach™ Partners with Arrive Alive DRIVE SOBER® Cronos Group

07 May 2019

Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel

Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO , May 07, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it is expanding its global infrastructure

09 April 2019

Cronos Group Inc. to Hold Conference Call on First Quarter 2019 Financial Results

TORONTO , April 09, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), will announce its financial results for the first quarter ended March 31, 2019 , and hold its First Quarter 2019 Earnings Conference Call on Thursday, May 9, 2019 at 8:30

26 March 2019

Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results

TORONTO , March 26, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), today announced financial results for the fourth quarter and full year ended December 31, 2018 .

08 March 2019

Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.

TORONTO , March 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (NYSE: MO) (“Altria”) has closed. As previously announced, Altria’s investment represents an approximate 45% ownership interest in Cronos Group . Altria also has a warrant to acquire additional ownership in Cronos Group , which is exercisable over the next four years. If exercised in full today, the warrant would increase Altria’s ownership in Cronos Group to approximately 55% and provide Cronos Group with additional proceeds of approximately C$1.4 billion .

04 March 2019

Cronos Group Inc. Exits Investment in Whistler Medical Marijuana Corporation

TORONTO , March 04, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), confirmed today that it has sold all of its common shares in the capital of Whistler Medical Marijuana Corporation (" Whistler "), representing approximately 19 percent

01 March 2019

Cronos Group Inc. to Hold Full Year and Fourth Quarter 2018 Earnings Conference Call

TORONTO , March 01, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), will announce its financial results and hold its Full Year and Fourth Quarter 2018 Earnings Conference Call on Tuesday, March 26, 2019 at 8:30 a.m. EDT .

21 February 2019

Cronos Group Inc. Shareholders Approve C$2.4 Billion Strategic Investment from Altria Group, Inc.

TORONTO , Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced that at a Special Meeting held today, the Company’s shareholders overwhelmingly approved the previously announced strategic investment agreement with Altria Group,

23 January 2019

Cronos Group Inc. Announces Closing of $65 Million Credit Facility

TORONTO , Jan. 23, 2019 /PRNewswire/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (" Cronos Group " or the " Company ") today announced that it has entered into a credit agreement (the " Credit Agreement ") with Canadian Imperial Bank of Commerce (" CIBC "), as administrative agent and

18 January 2019

Cronos Group Inc. Announces Mailing of Meeting Materials in Connection with Upcoming Special Meeting of Shareholders

TORONTO , Jan. 18, 2019 /PRNewswire/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (" Cronos Group " or the " Company ") is pleased to announce that the meeting materials for a special meeting of holders (the " Shareholders ") of common shares of the Company (the " Common Shares ") to be held on